Beigene Ltd (BGNE.OQ)
20 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|48||2010||Chairman of the Board, Chief Executive Officer, Founder|
|52||2015||Chief Financial Officer and Chief Strategy Officer|
|50||2014||Senior Vice President, Head of Regulatory Affairs|
|51||2014||Senior Vice President, Head of Clinical Development|
- BRIEF-Beigene Presents Clinical Data On Pamiparib In Chinese Patients With Ovarian Cancers At The American Association For Cancer Research Annual Meeting
- BRIEF-Beigene Initiates Global Phase 2 Trial Of Anti-PD-1 Antibody Tislelizumab
- BRIEF-Beigene Initiates Global Phase 2 Trial Of Anti-PD 1 Antibody Tislelizumab In Patients With Previously Treated Hepatocellular Carcinoma
- BRIEF-BeiGene Appoints J. Samuel Su To Its Board Of Directors
- China's Tasly to list biotech arm in $1 bln Hong Kong IPO - sources